Solventum Corporation

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Medpace Holdings

Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

SOLV or MEDP: Which Is the Better Value Stock Right Now?

Humana

Theravance Biopharma

Enigmatic investing legend Seth Klarman runs the Boston-based Baupost Group hedge fund that has around $27 billion in assets under management.

Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped

Watching what the smart money is buying can be a useful investment strategy.

26 Millionaires and Billionaires Can't Be Wrong. The One Stock All of Them Are Buying

Rentokil Initial PLC

AMERCO

Nelson Peltz isn't one to shy away from a fight.

Billionaire Nelson Peltz Unveiled 3 New Stocks in His Very Focused Portfolio

Doximity

Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Doximity (DOCS). But which of these two companies is the best option for those looking for undervalued stocks?

SOLV vs. DOCS: Which Stock Is the Better Value Option?

SOLV announces the launch of its V.A.C. Peel and Place Dressing for providing efficient and effective care in case of negative pressure wound therapy.

Solventum Shares May Gain on the Launch of Its New V.A.C Therapy

Amcor Plc

Air Products and Chemicals

Franklin Resources

Chevron

Fastenal

Federal Realty Investment Trust

Genuine Parts

Hormel Foods

Johnson & Johnson

Kenvue

Realty Income Corp

J. M. Smucker

Stanley Black & Decker

Sysco

Target

T. Rowe Price Group

V.F.

Walgreens

Exxon Mobil

The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue.

Buy 4 September Dividend Aristocrats And Watch 6

New V.A.C.® Peel and Place Dressing makes negative pressure wound therapy more accessible, less painful ST. PAUL, Minn.

Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy

IAMGOLD

Philip Morris

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus

GRAIL Inc

Stock spinoffs are a popular corporate strategy for unlocking shareholder value, but one that rarely pays off for investors.

2 Spinoff Stocks Down 16%. Should You Buy Now?

ST. PAUL, Minn. , Aug. 28, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m.

Solventum to Participate in Upcoming Investor Conferences

Chimera Investment

MDU Resources Group

Paramount Global

I sold Chimera. They were an underperforming REIT, even on their best days. I actually have received total proceeds of $10,967 and have recognized a total gain of $1,090.40. Warner Bro. Discovery, as my unrealized loss right now, is $1,600.

Lanny's Stock Sales Through June 30, 2024

ST. PAUL, Minn., Aug. 20, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced that its autonomous coding solution has received Toolbox designation from Epic in the Fully Autonomous Coding category.

Solventum autonomous coding listed in Epic Toolbox

Solventum's (SOLV) second-quarter results show resilience in MedSurg and Health Information Systems. Its shrinking margins pose concerns.

Solventum's (SOLV) Q2 Earnings Beat Estimates, ' 24 View Raised

Solventum Corporation (NYSE:SOLV ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Vik Chopra - Wells Fargo David Roman - Goldman Sachs Operator Good day. My name is Ellie, and I will be your conference operator for today.

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates functioning as a newly independent company.

Solventum's second-quarter profit falls 70% on higher expenses

Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Generated $355 million in cash from operations; free cash flow1 of $297 million Raises full-year 2024 organic sales growth and adjusted EPS guidance ST. PAUL, Minn.

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Enhabit Inc

We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through resolvable issues, and selling at attractive prices. I love buying businesses like this, and if it drops to my next buy price, we will add to it.

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.

Activist Trian has a few levers to pull to build shareholder value at Solventum

D.R. Horton

Pool

It's been a rough couple of weeks for the Magnificent Seven stocks. But it's been a boon for some other S&P 500 stocks.

11 Stocks Now Thrive As The Magnificent Seven Fall Apart

Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Capital took a stake in the healthcare company. According to insider sources, Trian Capital has taken a large stake in the company.

SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake

Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Fund Management took a stake in the healthcare company. According to insider sources, Trian has taken a large stake in the company.

SOLV Stock Alert: Solventum Pops as Activist Investor Trian Takes Stake

The move comes just months after 3M spun off the healthcare product company.

Solventum Stock Jumps as Activist Trian Discloses Stake

Activist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum , Bloomberg News reported on Monday, citing people with knowledge of the matter, sending shares of the company up 3.4% after the bell.

Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports

ST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close.

Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

News for Solventum Corporation Stock (SOLV)